These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22549500)

  • 21. Adjunctive aripiprazole in treatment-resistant bipolar depression.
    Ketter TA; Wang PW; Chandler RA; Culver JL; Alarcon AM
    Ann Clin Psychiatry; 2006; 18(3):169-72. PubMed ID: 16923655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
    De Schutter P; Bouckaert F; Peuskens J
    Tijdschr Psychiatr; 2011; 53(5):299-303. PubMed ID: 21538299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Syndrome of inappropriate antidiuretic hormone associated with aripiprazole.
    Yam FK; Jackson EA; Kwan BK
    Am J Health Syst Pharm; 2013 Dec; 70(23):2110-4. PubMed ID: 24249761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20 mg/day for the treatment of patients with acute exacerbations of schizophrenia.
    McEvoy JP; Daniel DG; Carson WH; McQuade RD; Marcus RN
    J Psychiatr Res; 2007 Dec; 41(11):895-905. PubMed ID: 17631314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aripiprazole induced Parkinsonism: A case report].
    Pasquier de Franclieu S; Germain C; Petitjean F
    Encephale; 2009 Oct; 35(5):496-8. PubMed ID: 19853725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of aripiprazole in treating mood disorders.
    García-Amador M; Pacchiarotti I; Valentí M; Sanchez RF; Goikolea JM; Vieta E
    Expert Rev Neurother; 2006 Dec; 6(12):1777-83. PubMed ID: 17181424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychosocial functioning in patients with schizophrenia treated with aripiprazole - an office-based real-world setting. Results from the German post-marketing surveillance study.
    Bergmann F; Zacher A; Nass A; Urban R; Werner C; Spevakné-Göröcs T; Kungel M; Ebrecht M; Modell S
    Pharmacopsychiatry; 2009 May; 42(3):101-8. PubMed ID: 19452378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, tolerability, and safety of aripiprazole following multiple oral dosing in normal healthy volunteers.
    Mallikaarjun S; Salazar DE; Bramer SL
    J Clin Pharmacol; 2004 Feb; 44(2):179-87. PubMed ID: 14747427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe psychotic exacerbation during combined treatment with aripiprazole/haloperidol after prior treatment with risperidone.
    Letmaier M; Painold A; Holl AK; Grohmann R; Vergin H
    Int J Psychiatry Clin Pract; 2012 Jun; 16(2):153-6. PubMed ID: 22211772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is a high dosage aripiprazole-clozapine combination an effective strategy for treatment-resistant schizophrenic patients? A case report.
    Pigato G; Toffanin T; Perini GI
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):153-5. PubMed ID: 18801403
    [No Abstract]   [Full Text] [Related]  

  • 31. Diabetic ketoacidosis associated with aripiprazole.
    Makhzoumi ZH; McLean LP; Lee JH; Ibe AI
    Pharmacotherapy; 2008 Sep; 28(9):1198-202. PubMed ID: 18752391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
    Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia due to aripiprazole: report of 2 cases.
    Lungu C; Aia PG; Shih LC; Esper CD; Factor SA; Tarsy D
    J Clin Psychopharmacol; 2009 Apr; 29(2):185-6. PubMed ID: 19512985
    [No Abstract]   [Full Text] [Related]  

  • 35. Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia.
    Ziegenbein M; Sieberer M; Calliess IT; Kropp S
    Aust N Z J Psychiatry; 2005 Sep; 39(9):840-1. PubMed ID: 16168043
    [No Abstract]   [Full Text] [Related]  

  • 36. Aripiprazole and the neuroleptic malignant syndrome.
    Strawn JR
    Schizophr Res; 2006 Jul; 85(1-3):298-9. PubMed ID: 16678389
    [No Abstract]   [Full Text] [Related]  

  • 37. A randomized, multicenter, double-blind, placebo-controlled study of the efficacy and safety of aripiprazole for the treatment of alcohol dependence.
    Anton RF; Kranzler H; Breder C; Marcus RN; Carson WH; Han J
    J Clin Psychopharmacol; 2008 Feb; 28(1):5-12. PubMed ID: 18204334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aripiprazole in combination with other antipsychotic drugs may worsen psychosis.
    Adan-Manes J; Garcia-Parajua P
    J Clin Pharm Ther; 2009 Apr; 34(2):245-6. PubMed ID: 19250146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.
    Palakurthi HB; Parvin MM; Kaplan S
    Clin Neuropharmacol; 2007; 30(1):47-51. PubMed ID: 17272970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole-induced psychosis: a case report of reexposure by stepwise up-titration.
    Kapusta ND; Mossaheb N; Barnas C; Fischer P
    J Clin Psychiatry; 2007 Sep; 68(9):1445-6. PubMed ID: 17915989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.